These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16298725)

  • 1. Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration.
    Rauhut AS; Dwoskin LP; Bardo MT
    Nicotine Tob Res; 2005 Dec; 7(6):901-7. PubMed ID: 16298725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bupropion on nicotine self-administration in rats.
    Rauhut AS; Neugebauer N; Dwoskin LP; Bardo MT
    Psychopharmacology (Berl); 2003 Aug; 169(1):1-9. PubMed ID: 12811464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate-dependent effects of bupropion on nicotine self-administration and food-maintained responding in rats.
    Stairs DJ; Dworkin SI
    Pharmacol Biochem Behav; 2008 Oct; 90(4):701-11. PubMed ID: 18602678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gamma-aminobutyric acid (GABA) and metabotropic glutamate receptors in nicotine reinforcement: potential pharmacotherapies for smoking cessation.
    Markou A; Paterson NE; Semenova S
    Ann N Y Acad Sci; 2004 Oct; 1025():491-503. PubMed ID: 15542754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preexposure to nicotine alters the subsequent locomotor stimulant effects of bupropion in rats.
    Wilkinson JL; Palmatier MI; Bevins RA
    Nicotine Tob Res; 2006 Feb; 8(1):141-6. PubMed ID: 16497608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the actions of bupropion on dependence-related effects of nicotine in rats.
    Shoaib M; Sidhpura N; Shafait S
    Psychopharmacology (Berl); 2003 Feb; 165(4):405-12. PubMed ID: 12451438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical and behavioral effects of bupropion and mecamylamine in the presence of nicotine.
    Vann RE; Rosecrans JA; James JR; Philibin SD; Robinson SE
    Brain Res; 2006 Oct; 1117(1):18-24. PubMed ID: 16949560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine and bupropion share a similar discriminative stimulus effect.
    Young R; Glennon RA
    Eur J Pharmacol; 2002 May; 443(1-3):113-8. PubMed ID: 12044800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bupropion hydrochloride produces conditioned hyperactivity in rats.
    Wilkinson JL; Bevins RA
    Physiol Behav; 2007 Apr; 90(5):790-6. PubMed ID: 17300819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.
    Levin ED; Rezvani AH; Xiao Y; Slade S; Cauley M; Wells C; Hampton D; Petro A; Rose JE; Brown ML; Paige MA; McDowell BE; Kellar KJ
    J Pharmacol Exp Ther; 2010 Mar; 332(3):933-9. PubMed ID: 20007754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of bupropion and nicotine on locomotor activation and dopamine release in vivo.
    Sidhpura N; Redfern P; Rowley H; Heal D; Wonnacott S
    Biochem Pharmacol; 2007 Oct; 74(8):1292-8. PubMed ID: 17678630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal nicotine exposure changes natural and drug-induced reinforcement in adolescent male rats.
    Franke RM; Park M; Belluzzi JD; Leslie FM
    Eur J Neurosci; 2008 Jun; 27(11):2952-61. PubMed ID: 18588535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H; Chambers LK; Coe JW; Glowa J; Hurst RS; Lebel LA; Lu Y; Mansbach RS; Mather RJ; Rovetti CC; Sands SB; Schaeffer E; Schulz DW; Tingley FD; Williams KE
    Neuropharmacology; 2007 Mar; 52(3):985-94. PubMed ID: 17157884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bupropion for the treatment of nicotine withdrawal and craving.
    Mooney ME; Sofuoglu M
    Expert Rev Neurother; 2006 Jul; 6(7):965-81. PubMed ID: 16831112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules.
    Green TA; Gehrke BJ; Bardo MT
    Psychopharmacology (Berl); 2002 Aug; 162(4):373-8. PubMed ID: 12172690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cue-induced reinstatement of nicotine-seeking behavior in rats: effect of bupropion, persistence over repeated tests, and its dependence on training dose.
    Liu X; Caggiula AR; Palmatier MI; Donny EC; Sved AF
    Psychopharmacology (Berl); 2008 Feb; 196(3):365-75. PubMed ID: 17932656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of bupropion on nicotinic receptor-evoked [(3)H]dopamine release from rat striatal synaptosomes and slices.
    Sidhpura N; Redfern P; Wonnacott S
    Eur J Pharmacol; 2007 Jul; 567(1-2):102-9. PubMed ID: 17477919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reboxetine: attenuation of intravenous nicotine self-administration in rats.
    Rauhut AS; Mullins SN; Dwoskin LP; Bardo MT
    J Pharmacol Exp Ther; 2002 Nov; 303(2):664-72. PubMed ID: 12388649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic effect of nicotine on serotonin transporter mRNA in the raphe nucleus of rats: reversal by co-administration of bupropion.
    Semba J; Wakuta M
    Psychiatry Clin Neurosci; 2008 Aug; 62(4):435-41. PubMed ID: 18778441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice.
    Biala G; Kruk M
    J Pharm Pharmacol; 2009 Apr; 61(4):493-502. PubMed ID: 19298697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.